FindTrial
Sign In

A study to see the effect of local anaesthetic drug to decrease the pain after laparoscopic removal of uterus.

Paracervical block for immediate post operative pain prevention after total laparoscopic hysterectomy: A Placebo controlled Randomized trial - PCB-TLH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037459
Enrollment
66
Registered
2021-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N924- Excessive bleeding in the premenopausal period Health Condition 2: D259- Leiomyoma of uterus, unspecified

Interventions

Intervention1: Paracervical block: only one dose at time of surgery. Control Intervention1: 0.9% Normal Saline: only one dose at time of surgery.

Sponsors

AIIMS Jodhpur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients undergoing Laparoscopic Hysterectomy for benign conditions and for premalignant lesions requiring simple TLH without additional procedures ( like lymphnode dissection) 2. Patients consenting for the study.

Exclusion criteria

Exclusion criteria: 1. TLH for Extensive Endometriosis. 2. TLH with Pelvic lymph nodal dissection in cases of Carcinoma Cervix, Carcinoma Endometrium. 3. Uterus of size 14 weeks or higher. 4. Allergy to Bupivacaine. 5. Patients not giving consent.

Design outcomes

Primary

MeasureTime frame
Difference in the VAS Score at 30 minutes and at 60 minutes after TLH in the subjects that received 0.5% Bupivacaine v/s those who received Placebo.Timepoint: 30 minutes and at 60 minutes—

Secondary

MeasureTime frame
Duration of hospital stayTimepoint: 48 hours—

Countries

India

Contacts

Public ContactDr Sumanjot Kaur

AIIMS Jodhpur

longshanks28@gmail.com8003996917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026